**Synopsis**
Mrs. Eleanor Vance, a 68-year-old female, was initially diagnosed with Stage IIIB non-small cell lung cancer (NSCLC) in 2022. Histopathology revealed adenocarcinoma. She completed concurrent chemoradiation and is currently on maintenance immunotherapy with pembrolizumab. There is no evidence of disease recurrence or metastasis at this time.
**Consent**
"The patient provided verbal consent to use the AI scribe during this visit, understanding its purpose, potential benefits, and any associated privacy and security risks"
**History of Present Illness**
Mrs. Vance presents today for routine follow-up. She reports mild fatigue, which she attributes to her ongoing immunotherapy. She denies any new cough, shortness of breath, chest pain, or other concerning symptoms. She reports she has been tolerating her pembrolizumab well. Her last CT scan, performed on 15 October 2024, showed no evidence of disease progression.
**Physical Examination**
- **General:** Appears well, performance status is ECOG 1.
- **Cardiovascular:** Regular rate and rhythm, no murmurs.
- **Respiratory:** Clear to auscultation bilaterally.
- **Gastrointestinal:** Soft, non-tender abdomen.
- **Neurological:** Alert and oriented.
- **Other:** No palpable lymphadenopathy.
**Lab Results**
- CEA: 1.8 ng/mL (within normal limits)
- Full blood count: Within normal limits
- Renal and liver function tests: Within normal limits
**Diagnostics**
- CT Chest/Abdomen/Pelvis (15 October 2024): No evidence of recurrent or metastatic disease.
**Problems / Past Medical History**
- Non-small cell lung cancer (Stage IIIB, adenocarcinoma)
- Hypertension
**Procedure / Surgical History**
- Right upper lobectomy (2022)
- Mediastinal lymph node dissection (2022)
- Port placement
**Medications**
- Pembrolizumab 200mg IV every 3 weeks
- Amlodipine 5mg daily
**Allergies**
- NKDA
**Assessment / Plan**
1. Stable disease, tolerating pembrolizumab well.
2. Continue pembrolizumab as scheduled.
3. Discussed fatigue management strategies, including rest and hydration.
4. Schedule follow-up appointment in 3 months and repeat CT scan in 6 months.
**Synopsis**
[Brief summary of the patient’s oncological background including primary cancer diagnosis, histopathology, initial staging, year of diagnosis, current treatment phase, and any known metastases or recurrence] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely. Write as a concise paragraph in full sentences.)
**Consent**
"The patient provided verbal consent to use the AI scribe during this visit, understanding its purpose, potential benefits, and any associated privacy and security risks"
**History of Present Illness**
[Detailed description of current concerns including new symptoms, progression of disease, treatment side effects, changes in function or pain levels, treatment response, or deterioration; include dates where available] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely. Write as thematic paragraphs in full sentences.)
**Physical Examination**
- **General:** [Appearance, performance status, cachexia, distress] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely. Write in complete sentences.)
- **Cardiovascular:** [Heart sounds, pulses, blood pressure] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely. Write in complete sentences.)
- **Respiratory:** [Breath sounds, effort, auscultation findings] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely. Write in complete sentences.)
- **Gastrointestinal:** [Abdominal tenderness, masses, hepatosplenomegaly] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely. Write in complete sentences.)
- **Neurological:** [Orientation, sensation, mobility, neuropathy] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely. Write in complete sentences.)
- **Other:** [Lymphadenopathy, surgical sites, skin lesions] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely. Write in complete sentences.)
**Lab Results**
- [Key tumor markers, full blood count, renal or liver function tests, CRP/ESR, or other tests relevant to cancer progression or treatment toxicity] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely. Use bullet format.)
**Diagnostics**
- [Imaging reports (e.g., CT, MRI, PET) with summary interpretation and dates] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely. Use bullet format.)
**Problems / Past Medical History**
- [Chronic illnesses, comorbidities, or past cancer-related complications] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely. Use bullet format.)
**Procedure / Surgical History**
- [Oncological surgeries, ports, biopsies, or relevant procedures] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely. Use bullet format.)
**Medications**
- [Chemotherapy, hormone therapy, immunotherapy, supportive agents, and symptom management drugs] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely. Use bullet format.)
**Allergies**
- [Drug or contrast agent allergies with reaction type] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely. Use bullet format.)
**Assessment / Plan**
1. [Clinical status summary: progression, response, or stability] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely. Write as a complete sentence.)
2. [Planned interventions: chemotherapy, immunotherapy, radiotherapy, referrals] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely. Write as a complete sentence.)
3. [Symptom or psychosocial management strategies] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely. Write as a complete sentence.)
4. [Follow-up or imaging review schedule] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely. Write as a complete sentence.)
(Never invent patient details, assessments, plans, interventions, evaluations, or ongoing care. Use only the transcript, contextual notes, or clinical note as your source. If any placeholder lacks data, omit it completely. Follow this template exactly to prevent hallucinations or misinterpretation.)